Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study Evaluating the Safety and Efficacy of ABT-751 in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer

NCT00354562 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00354562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00354562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study Evaluating the Safety and Efficacy of ABT-751 in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer
Lead sponsor
Abbott
Phase
Phase 1/2
Overall status
Terminated
Start date
February 28, 2007
Completion date
Not reported
Enrollment
75 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, non-small cell lung cancer